Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Active
SPE2DP-26-R-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-26-R-0002 is a federal request for a firm-fixed price, indefinite-delivery, indefinite-quantity contract to establish a source of supply for the Influenza Virus Vaccine, Southern Hemisphere 2027 Formula. The contract, issued by the Medical Supply Chain Pharmacy FSA for the Department of Defense, covers a twelve month term for quadrivalent or trivalent vaccines suitable for individuals aged six months and older. The required product consists of 0.5 ML doses provided in packages of ten syringes. All quantities must be delivered to the Defense Distribution Center in Susquehanna, Pennsylvania, by March 31, 2027, with delivery appointments coordinated through DLA Distribution Susquehanna. Proposals must be submitted exclusively via the DLA Internet Bid Board System by October 14, 2026. Evaluation is based on price and the ability to meet all solicitation terms, including the provision of FDA approval for manufacturers or a manufacturer's Letter of Commitment for dealers. The contractor is responsible for ensuring products comply with USP requirements and the Drug Supply Chain Security Act. Strict packaging and marking standards apply, specifically Medical Marking Standard No. 1D, with rigorous cold chain requirements for refrigerated items (2 to 8 degrees Celsius) and frozen items (-25 to -10 degrees Celsius), including the use of DLA-compatible temperature monitors. Invoicing and payment will be processed electronically through the Wide Area Workflow system.

General Info

DoD seeks firm-fixed price contract for 2027 Southern Hemisphere Influenza Virus Vaccines.

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

4

Solicitation SPE2DP-26-R-0002

PDF, High priority: read this firstrfp
High

Solicitation SPE2DP-26-R-0002

PDF, High priority: read this firstrfp
High

DIBBS Proposal Upload Instructions

PDF, Low priorityother
Low

How to Upload Proposal in DIBBS

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Sources Sought

Type Changed

Sources Sought → Presolicitation

Type Changed

Presolicitation → Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts
Rosbert Jones

Full Description

Show more
, and that the product conforms to the producers' own drawings, specifications, standards, and quality assurance practices, and is the same product offered for sale in the commercial market-place. The government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
SPE2DP-26-R-0002
Form (CONTINUED)
Responsibility for Inspection: Unless otherwise specified in the contract or purchase order, the contractor is responsible for the performance of all inspection requirements as specified herein. Except as otherwise specified in the contract or purchase order, the contractor may use his own or any facilities suitable for the performance of the inspection requirements specified herein, unless disapproved by the Government. The Government reserves the right to perform any of the inspections set forth in the specification where such inspections are deemed necessary to assure supplies and services conform to prescribed requirements. Records: Records of examinations and tests performed by or for the contractor shall be maintained by the contractor and made available to the Government upon the Government's request, at any time, or from time to time, during the performance of the contract and for a period of three years after delivery of the supplies to which such records relate.
Inspection: Inspection, as used herein, is defined as both examination (such as visual or auditory investigation without the use of special laboratory appliances or procedures) and testing (determination by technical means of physical and chemical properties) of the item. Examination and Testing: Examination and testing shall be conducted on the product in accordance with commercial practice. The sampling for examination and testing shall be in accordance with commercial practice.
Metric Products.: Products manufactured to metric dimensions will be considered on an equal basis with those manufactured using inch-pound units. Dimensions and tolerances specified shall be converted using conversion tables contained in the latest revision of ASTM E 380. Other Quality Assurance Provision: Shall be as indicated in the contract/purchase order and/or SOW. H. PREPARATION FOR DELIVERY
Delivery appointments are required: Your truckers/dispatchers/brokers/etc. should have the above information readily available when calling to schedule delivery appointments as follows: DLA Distribution Susquehanna (New Cumberland, PA) Carriers must email a copy of the Commercial Bill(s) of Lading CBL(s) to prelodge@dla.mil when requesting a delivery appointment or can call 1-800-307-8496. NSN/Part Number: 3RFQ3SEESOW

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
The Defense Logistics Agency Troop Support is soliciting Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringes under solicitation SPE2DP-26-R-0001, with a sole source justification under FAR 6.302-1 due to the unique nature of the product and regulatory requirements. The acquisition will follow Part 12 procedures for commercial items, resulting in a firm-fixed-price, indefinite delivery, indefinite quantity contract with an 18-month base term. The minimum order is 277,760 units, with an estimated and maximum quantity of 277,760 and 394,240 units respectively. Vaccines must be FDA-approved prior to the solicitation’s closing date and must comply with MPID Number 5 dated July 23, 2024. All deliveries are FOB destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, with a 120-day production lead time following issuance of each DD1155 delivery order. Inspection and acceptance occur at the delivery point, and the contractor is responsible for certification of conformity with all specifications including FDA regulations and labeling requirements. All packaging, marking, and labeling must adhere to strict government standards including MIL-STD-2073-1 for preservation, MIL-STD-129 for shipping labels, and MIL-STD-130 for item identification. Units must be marked with the NSN, CAGE code, part number, contract number, preservation method and date, and transaction control number, with commercial preservation denoted as “COMM’L” and military as “M” followed by the method and date. Intermediate and exterior containers require bar codes compliant with DoD logistics standards, and hazardous materials necessitate a Shipper’s Declaration for Dangerous Goods and Safety Data Sheets. Shelf life must include at least 12 months remaining at time of delivery for Type I items, with expiration and manufacture dates clearly marked. Each shipment must include a destination label addressed to DODAAC SV3100, and all documentation must be in English using durable, legible markings. The contract requires electronic submission via the DIBBS portal and prohibits paper solicitations. Contractors must maintain inspection records for three years post-delivery and comply with all applicable federal regulations including the Federal Food, Drug, and Cosmetic Act and 49 CFR for hazardous materials. No socioeconomic set-asides apply,
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 28 days
View Details
NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

8 days ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS